FDA Critical Path Initiative. U.S. Food and Drug Administration. https://www.fda.gov/science-research/critical-path-initiative
Decision-Making at FDA. U.S. Food and Drug Administration. https://www.fda.gov/science-research/about-science-research-fda/decision-making-fda
Critical Thinking and Problem Solving for FDA Professionals. U.S. Food and Drug Administration. https://collaboration.fda.gov/pi3c6nyvz7v/
Building FDA’s 21st Century Review Process. U.S. Food and Drug Administration. https://www.fda.gov/news-events/fda-voices-perspectives-fda-leadership-and-experts/building-fdas-21st-century-review-process
White Paper: Advancing Regulatory Science at FDA. U.S. Food and Drug Administration. https://www.fda.gov/science-research/science-and-research-special-topics/advancing-regulatory-science-fda-white-paper
Critical Thinking, Decision Making, and the FDA. U.S. Food and Drug Administration. https://collaboration.fda.gov/p5qkl9a7vwh/
U.S. Food and Drug Administration. (2018). Computerized Systems Used in Clinical Investigations. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/computerized-systems-used-clinical-investigations
International Society for Pharmaceutical Engineering (ISPE). (2020). GAMP 5 – A Risk-Based Approach to Compliant GxP Computerized Systems. https://ispe.org/publications/guidance-documents/gamp-5-risk-based-approach-compliant-gxp-computerized-systems
U.S. Food and Drug Administration. (2003). Guidance for Industry: Part 11, Electronic Records; Electronic Signatures — Scope and Application. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application
U.S. Food and Drug Administration. (2021). Data Integrity and Compliance With Drug CGMP: Questions and Answers. https://www.fda.gov/media/119267/download
U.S. Food and Drug Administration. (2019). Electronic Source Data in Clinical Investigations. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/electronic-source-data-clinical-investigations
U.S. Food and Drug Administration. (2020). Quality Management System (QMS) Implementation. https://www.fda.gov/media/89419/download
U.S. Food and Drug Administration. (2018). Computer Software Assurance for Manufacturing, Operations, and Quality System Software. https://www.fda.gov/media/119457/download
U.S. Food and Drug Administration. (2021). Data Integrity and Compliance With Drug CGMP: Questions and Answers. https://www.fda.gov/media/119267/download
U.S. Food and Drug Administration. (2020). Quality Management System (QMS) Implementation. https://www.fda.gov/media/89419/download
International Society for Pharmaceutical Engineering (ISPE). (2020). GAMP 5 – A Risk-Based Approach to Compliant GxP Computerized Systems. https://ispe.org/publications/guidance-documents/gamp-5-risk-based-approach-compliant-gxp-computerized-systems
U.S. Food and Drug Administration. (2018). Computer Software Assurance for Manufacturing, Operations, and Quality System Software. https://www.fda.gov/media/119457/download
U.S. Food and Drug Administration. (2017). Design Considerations and Pre-Market Submission Recommendations for Interoperable Medical Devices. https://www.fda.gov/media/80958/download
U.S. Food and Drug Administration. (2013). Applying Human Factors and Usability Engineering to Medical Devices. https://www.fda.gov/media/80481/download
U.S. Food and Drug Administration. (2021). Content of Premarket Submissions for Management of Cybersecurity in Medical Devices. https://www.fda.gov/media/122438/download
FDA History. U.S. Food and Drug Administration. https://www.fda.gov/about-fda/fda-history
FD&C Act & Related Statutes. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/selected-amendments-fdc-act/fdc-act-related-statutes
History of FDA’s Authority Over Cosmetics. U.S. Food and Drug Administration. https://www.fda.gov/cosmetics/cosmetics-laws-regulations/history-fdas-authority-over-cosmetics
Orphan Drug Act: Relevant Excerpts from the Orphan Drug Act. U.S. Food and Drug Administration. https://www.fda.gov/industry/orphan-drug-act-relevant-excerpts-orphan-drug-act
Federal Food, Drug, and Cosmetic Act. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/selected-amendments-fdc-act/federal-food-drug-and-cosmetic-act
International Society for Pharmaceutical Engineering (ISPE). (2020). GAMP 5 – A Risk-Based Approach to Compliant GxP Computerized Systems, Second Edition. https://ispe.org/publications/guidance-documents/gamp-5-risk-based-approach-compliant-gxp-computerized-systems
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). (2005). ICH Q9: Quality Risk Management. https://database.ich.org/sites/default/files/Q9%20Guideline.pdf
Gambrill, E., & Rasi, G. (2021). Current Status of GAMP 5: A Review of the Latest Version and What It Means for Industry. Pharmaceutical Engineering, 41(2), 44-49. https://www.ispe.org/publications/gamp-5-international-standard
International Society for Pharmaceutical Engineering (ISPE). (2021). GAMP 5 FAQs – Edition 2. https://ispe.org/frequently-asked-questions/gamp-5-edition-2
Cheng, B. (2019). GAMP 5: A Decade of Evolution. Pharmaceutical Engineering, 39(5), 14-19. https://www.ispe.org/publications/gamp-5-decade-evolution
U.S. Food and Drug Administration (FDA). (2021). Design Controls. Retrieved from https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/design-controls
European Medicines Agency (EMA). (2021). Medical Devices. Retrieved from https://www.ema.europa.eu/en/human-regulatory/overview/medical-devices
International Organization for Standardization (ISO). (2021). ISO 13485:2016 – Medical devices — Quality management systems — Requirements for regulatory purposes. Retrieved from https://www.iso.org/standard/59752.html
Papanicolas, I., Woskie, L. R., & Jha, A. K. (2018). Health care spending in the United States and other high-income countries. JAMA, 319(10), 1024-1039.
He, J., & Baxter, S. L. (2019). Encountering Regulatory Uncertainties in Medical Device Development: A Practitioner’s Perspective. IEEE Access, 7, 35697-35706.
U.S. Food and Drug Administration (FDA). (2021). Quality System (QS) Regulation/Medical Device Good Manufacturing Practices. Retrieved from https://www.fda.gov/medical-devices/postmarket-requirements-devices/quality-system-qs-regulationmedical-device-good-manufacturing-practices
International Organization for Standardization (ISO). (2021). ISO 13485:2016 – Medical devices — Quality management systems — Requirements for regulatory purposes. Retrieved from https://www.iso.org/standard/59752.html
Health Canada. (2021). Guidance Document: Quality Management Systems – Medical Devices – Guidance on Corrective Action and Preventive Action and Related QMS Processes. Retrieved from https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices/activities/announcements/guidance-document-quality-management-systems.html
Swarbrick, P. P., & Patole, S. P. (2015). Failure mode and effect analysis. Pediatric Surgery International, 31(9), 817-822.
Wyatt, J. C., & Spiegelhalter, D. (1991). Evaluating medical expert systems: What to test and how?. Computers in biology and medicine, 21(6), 363-382.
International Electrotechnical Commission (IEC). (2015). IEC 62304: Medical device software — Software life cycle processes. Retrieved from https://www.iso.org/standard/38504.html
U.S. Food and Drug Administration (FDA). (2021). Software as a Medical Device (SaMD). Retrieved from https://www.fda.gov/medical-devices/digital-health/software-medical-device-samd
European Medicines Agency (EMA). (2020). Regulatory guidance for medical device software: Medical Device Coordination Group (MDCG) guidance. Retrieved from https://www.ema.europa.eu/en/human-regulatory/overview/medical-devices/software-medical-device
Raza, S., & Standing, C. (2019). Best Practices for Software Validation. Journal of Validation Technology, 25(3), 18-23.
FDA. (2021). Digital Health. Retrieved from https://www.fda.gov/medical-devices/digital-health
Pecht, M., & Kim, H. (2013). Reliability Engineering. John Wiley & Sons.
Miret, J., & Pons, E. (2011). Reliability engineering in the healthcare sector: A literature review. Reliability Engineering & System Safety, 96(11), 1470-1477.
Khezrimotlagh, D., & Nezafat, N. (2013). Application of Reliability Engineering in Medical Devices. World Academy of Science, Engineering and Technology, International Journal of Biomedical and Biological Engineering, 7(6), 384-387.
ISO 14971:2019. Medical devices – Application of risk management to medical devices. International Organization for Standardization.
FDA. (2021). Medical Device Reliability and Performance. Retrieved from https://www.fda.gov/medical-devices/learning-resources/medical-device-reliability-and-performance
. U.S. Food and Drug Administration (FDA). (2021). Design History File (DHF), Technical File and Design Dossier – Guidance for Industry and Food and Drug Administration Staff. Retrieved from https://www.fda.gov/media/82203/download
U.S. Food and Drug Administration (FDA). (2021). Device Master Record – Guidance for Industry and FDA Staff. Retrieved from https://www.fda.gov/media/114460/download
ISO 13485:2016. Medical devices — Quality management systems — Requirements for regulatory purposes. International Organization for Standardization.
International Medical Device Regulators Forum (IMDRF). (2019). Clinical Evidence for Medical Devices: A Brief Overview of the Current Regulatory Landscape. Retrieved from https://www.imdrf.org/docs/imdrf/final/technical/imdrf-tech-190609-umd-n41-clinical-evidence-overview.pdf
AAMI TIR45:2012. Guidance on the use of AGILE practices in the development of medical device software. Association for the Advancement of Medical Instrumentation.
U.S. Food and Drug Administration. (2019). Consent Decree Information. [https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/consent-decree-information](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/consent-decree-information)
U.S. Food and Drug Administration. (2019). How to Comply with FDA’s Requirements for Quality Systems (Quality System Regulation). [https://www.fda.gov/medical-devices/postmarket-requirements-devices/how-comply-fdas-requirements-quality-systems-quality-system-regulation](https://www.fda.gov/medical-devices/postmarket-requirements-devices/how-comply-fdas-requirements-quality-systems-quality-system-regulation)
Morgan Lewis. (2017). Consent Decrees: What Companies Need to Know. [https://www.morganlewis.com/pubs/consent-decrees-what-companies-need-to-know](https://www.morganlewis.com/pubs/consent-decrees-what-companies-need-to-know
